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Neural crestThe majority of vertebrate species have a layer of hyaline cartilage within the ﬁbrous sclera giving an extra
degree of support to the eyeball. In chicks, this is seen as a cuplike structure throughout the scleral layer.
However, the mechanisms that control the development of scleral cartilage are largely unknown.
Here we have studied the phases of scleral cartilage development and characterised expression proﬁles of
genes activated during the cartilage differentiation programme. CART1 and SOX9, the earliest markers of pre-
committed cartilage, are expressed in the mesenchyme surrounding the optic cup. Later AGGRECAN, a matrix
protein expressed during chondrocyte differentiation, is also expressed. The expression of these genes is lost
following early removal of the optic cup, suggesting a role for this tissue in inducing scleral cartilage. By
grafting young retinal pigment epithelium (RPE) and retina into cranial mesenchyme in vivo, it was found
that RPE alone has the ability to induce cartilage formation.
There are some exceptions within the vertebrates where scleral cartilage is not present; one such example is
the placental mammals. However, we found that the cartilage differentiation pathway is initiated in mice as
seen by the expression of Cart1 and Sox9, but expression of the later cartilage marker Aggrecan is weak.
Furthermore, cartilage forms in mouse peri-ocular mesenchyme micromass culture. This suggests that the
process halts in vivo before full differentiation into cartilage, but that murine scleral mesenchyme has
retained the potential to make cartilage in vitro.
RA, Wnts and Bmps have been linked to the cartilage development process and are expressed within the
developing RPE. We ﬁnd that RA may have a role in early scleral cartilage development but is not likely to be
the main factor involved.
These data reveal the course of scleral cartilage formation and highlight the key role that the optic cup plays
in this process. The driving element within the optic cup is almost certainly the retinal pigmented
epithelium.ell).
 license.© 2010 Elsevier Inc. Open access under CC BY license.Introduction
The vertebrate eye develops as bilateral diencephalic outgrowths,
which protrude into surrounding peri-ocular mesenchyme. These
contact the surface ectoderm before invaginating to form optic cups
composed of inner and outer neural ectoderm layers—the neural
retina and retinal pigment epithelium (RPE) respectively (Fig. 1A).
With development, these layers divide and differentiate into their
mature cells types, while the surrounding mesenchyme condenses
and develops into the choroid and scleral layers (Figs. 1A, B). The
choroid layer consists of a vascular network supplying the outer
retina. It also contains neural crest-derived melanocytes that pigment
just prior to birth (Lopes et al., 2007). The sclera, which provides
the eye with structural integrity is derived solely from neural crest(Le Lievre and Le Douarin, 1975; Johnston et al., 1979; Gage et al.,
2005) and is a dense ﬁbrous layer continuous with the cornea. The eye
therefore develops from a number of distinct tissues from different
developmental origins involving tightly controlled reciprocal signal-
ling to coordinate growth and development.
In the majority of vertebrate species the sclera contains cartilage
and in some cases also bone, which give an extra degree of support to
the eyeball (Caprette et al., 2004; Franz-Odendaal and Vickaryous,
2006). Commonly this is a hyaline cartilage layer forming a cuplike
structure within the sclera. In many teleosts, reptiles and birds the
sclera also forms ossicles—bony plates found in a ring surrounding the
anterior region of the eye (Franz-Odendaal and Vickaryous, 2006;
Franz-Odendaal, 2008). Althoughmost vertebrates develop a cartilage
layer within the sclera, placental mammals, snakes, hagﬁsh and
lamprey do not (Caprette et al., 2004). Furthermore, in some
amphibians, scleral cartilage is absent at the tadpole stage but present
after metamorphosis (Franz-Odendaal and Hall, 2006). The mechan-
isms that control the development of the scleral cartilage are largely
Fig. 1. Cartilage is found within the scleral layer of the eye. (A) Schematic showing the structure of the eye early in development, HH stages 13–27 (E2–E5) composed of the CNS-derived
layers the retinal pigment epithelium (RPE) and retina surrounded by the neural crest-derived mesenchyme (mes). (B) Schematic showing the structure of the mature eye with all its
layers. (C–D)Alcian blue and alizarin red staining ofwhole-mountHH stage 36 (E10) chick embryos showing scleral cartilage (sc) surrounding the eyes, except in themost anterior region
of the eye near the lens (L). (E–F) Alcian blue and nuclear fast red staining on sections, of HH stage 36 (E10) chick showing scleral cartilage (arrows in E) within the sclera layer, adjacent
to the choroid (ch) and at a short distance from the RPE (F). NT, neural tube; L, lens; ub, upper beak; lb, lower beak; r, retina; c, cartilage; 1—retina; 2—RPE; 3—choroid; 4—scleral
cartilage; 5—sclera.
41H. Thompson et al. / Developmental Biology 347 (2010) 40–52unknown and equally the mechanisms that prevent its formation in
the mammals, agnatha and snakes are not understood.
Cartilage development has been extensively studied, most notably
in the developing limb buds (reviewed by Shimizu et al., 2007). Here
it has been shown that chondrogenesis occurs in stages beginning
with mesenchymal cell condensation and proliferation followed by
differentiation of chondrocytes and secretion of the cartilage matrix.
The ﬁrst phase is associated with the expression of cell adhesion
molecules and the transcription factors Sox9 and Cart1 (Alx1) (Zhao
et al., 1994;Wright et al., 1995). The secondary phases of chondrocyte
differentiation and maturation correlates with expression of the
transcription factors Sox5 and Sox6 (Lefebvre et al., 1998) and the
extracellular matrix proteins collagen type II (Swalla et al., 1988) and
aggrecan. In the majority of embryonic cartilage elements a process of
hypertrophy and replacement by bone then takes place. However,
there are isolated examples of where this does not occur and cartilage
persists into adulthood, including the scleral cartilage. This gene
expression sequence and the time window over which cartilage
develops are similar in all mesodermal skeletal elements. The period
over which neural crest-derived craniofacial cartilage differentiates is
much longer however and few studies draw attention to this key
difference. This delay in differentiation may reﬂect the need tocoordinate growth with adjacent neural tissue and implies complex
signalling between neural and skeletal structures.
The induction of cartilage development in both mesodermal and
neural crest tissues is known to involve epithelial–mesenchymal
interactions. This is particularly well characterised in the limb
(mesodermal) (Hall, 1981) and in themandible (neural crest derived)
(Hall, 1981; Haworth et al., 2007), where surface ectoderm induces
cartilage. More recently, the endoderm has been implicated in
inducing pharyngeal cartilage development (Couly et al., 2002;
Walshe and Mason, 2003; Crump et al., 2004). However, the
developing scleral cartilage is not located close to either a surface
ectoderm or an endoderm. Several in vitro studies in the 1970s
suggested that the neuro-ectodermally derived RPE may induce
cartilage (Newsome, 1972; Stewart and McCallion, 1975); however,
they lacked speciﬁc markers to prove this.
Here, we will examine the sequence of scleral cartilage develop-
ment in chick using histology and in situ hybridisation against various
cartilage markers. We will also examine the affect of enucleation on
scleral cartilage formation, examine which tissues in the optic cup can
induce cartilage formation in vivo and look for the secreted molecules
that may be involved. Finally, to determine if mammalian sclera
initiates cartilage development we will examine expression of
42 H. Thompson et al. / Developmental Biology 347 (2010) 40–52cartilage markers in mouse embryos and the ability of the mouse
scleral mesenchyme to make cartilage.Methods
Animals
Fertile white leghorn chicken eggs (Henry Stewart and Co. Ltd,
Lincolnshire, UK) and Japanese Coturnix quail eggs (www.quails-
in-essex.co.uk) were incubated at 37 °C, staged according to
Hamburger and Hamilton (1951) or Ainsworth et al. (2010) and
the extra-embryonic membranes removed before ﬁxing in 4% PFA
in PBS.
CD1 mice were obtained from in-house breeding or a gift from A.
Basson (Craniofacial department, KCL). C57 (bl) were ordered from
Charles River UK Ltd, Margate. Noon on the day the vaginal plug was
found was considered embryonic day 0.5 (E0.5). Pregnant mothers
were killed by cervical dislocation and the embryos removed and
ﬁxed in 4% PFA in PBS. All conditions and all experimental procedures
were in accordance with the UK Animals (Scientiﬁc Procedures) Act
1986 and associated guidelines.Enucleations
A hole was made in the blunt end of an embryonic day 2 (E2) egg
and 2 ml of albumin removed. Sellotape was stuck to the upper
surface and a “window” (approximately 1×2 cm) was cut to reveal
the embryo and an opening made in the chorion and amnion directly
above the eye. Embryos at HH stage 12–14were selected for operation
and a ﬂame sharpened tungsten needle was used to carefully cut
around the optic cup, sever the optic stalk and remove the optic cup
from the egg. The eggs were sealed with Sellotape and re-incubated
before collecting at various points up to HH stage 39 (E13) and ﬁxing
in 4% PFA in PBS overnight.Grafting
HH stage 19 (E3) chick or Q stage 19 (E3) quail embryos were
enucleated and the eye transferred to HBSS (without calcium and
magnesium, Sigma, Dorset, UK). Using a needle and ﬁne forceps the
RPE was peeled away from the retina. Each tissue was then sliced into
3–4 pieces for grafting. For the host, HH stage 12–14 (E2) chick
embryo was enucleated and the graft was pushed into the cavity left a
by optic cup removal. In other experiments, a HH stage 18-19 (E3)
chick egg was opened and a small incision was made in the ectoderm
temporal to the eye using a needle. The graft was pushed into the
ectoderm incision using needles. The eggs were sealed with Sellotape
and re-incubated for up to 7 days (HH stage 36) before collecting and
ﬁxing in 4% PFA in PBS overnight.
For mouse grafting, E10.5 or E11.5 embryos were harvested and
transferred to L15 media (Sigma) on ice before preparing the tissue
for grafting as above.Fig. 2. The development of chicken scleral cartilage. (A–C) In situ hybridisation showing exp
whole-mount (A, B, C) and in section (A′, B′, C′). Images are of the nasal (A′, B′) or dorsal
mesenchyme adjacent to the RPE (arrow; A′) with stronger expression seen nasally seen her
cup seen here at HH stage 24 (E4; B, B′). AGGRECAN is expressed strongly as a thin band arou
28and 29 (E6). Alcian blue staining of HH stage 34 (E8) chick in whole mount (D) and in sec
from the RPE. (E–G) H&E staining on parafﬁn sections at HH stages 22–24 (E4; E), HH stage
condense close to the RPE (E), by E6 the mesenchyme is highly packed but no deﬁnitive chon
deﬁnitive cartilage (sc) is seen adjacent to the choroid. (H–J) H&E staining on parafﬁn secti
around the eye. Cartilage development is less advanced in the posterior (I) than anterior re
retina development. CART1 is expressed from HH stages 15–29 (E2.5bE6), SOX9 is seen from
mesenchyme; AGG, AGGRECAN.RA bead implantation
AG1X-2 beads were soaked in 0.1 mg/ml or 1 mg/ml retinoic acid
(RA; Sigma) dissolved in dimethylsulfoxide (DMSO) for 3 h, rinsed in
PBS then in L-15 media. Embryos were enucleated as above and a RA
bead was pushed into the cavity left by the removed optic cup. The
eggs were sealed with Sellotape and re-incubated for 2 days (HH
stages 21–23) before collecting and ﬁxing in 4% PFA in PBS overnight.
Control embryos were treated with DMSO-soaked beads.
Micromass culture
Embryonic day 12.5 embryos were collected in HBSS media
(calcium- and magnesium-free; Sigma) and the head was trimmed
to leave only the area around the eye before incubating in 2% trypsin
for 30 minutes at 4 °C. Following this the tissue was washed in L15
(Sigma) with 10% FCS (Sigma) and the ectoderm and optic cup tissue
was carefully peeled away from themesenchyme leaving a small band
of peri-ocular mesenchyme. This was then cultured as a micromass
(Cottrill et al., 1987) at 2×107 cells per ml, for 4 days in Hams F12/
DMEM media (1:1) with 10% FCS and penicillin/streptomycin. The
cultures where then ﬁxed in 4% PFA, rinsed in 3% acetic acid and
stained with 1% Alcian blue/3% acetic acid (1:1) to label cartilage
nodules.
Alcian blue staining of cartilage
Embryonic heads were dehydrated in 95% ethanol for 2 days,
soaked in acetone for 2 h before staining with 0.3% Alcian blue (VWR,
Poole, UK) in 70% ethanol (with or without a 0.1% alizarin red (Sigma)
in 95% ethanol) in acetic acid and 70% ethanol at a ratio of 1:1:1:17
(freshly made), for 5 days at 37 °C. Embryos were rinsed in distilled
water, cleared in a decreasing concentration of 1% potassium
hydroxide in glycerol and stored in 100% glycerol.
For staining of tissue sections, embryonic heads were embedded in
parafﬁn and sectioned transversely at 5 μm, before dewaxing and
rehydrating. Sectionswere then stainedwith a 1% aqueous Alcian blue
in 1% aqueous acetic acid solution for 10 minutes, followed by
3 minutes in a nuclear fast red solution (Vector Labs, Peterborough,
UK), then dehydrated, washed in xylene and mounted with DPX.
Haematoxylin and eosin staining
Embryonic heads were ﬁxed in 4% PFA, embedded in parafﬁn wax
before sectioning transversely at 8–16 μm. Slides were dewaxed,
rehydrated and stained with haematoxylin and eosin (H&E) before
dehydrating and mounting in DPX.
In situ hybridisation
Whole-mount in situ hybridisation was performed (Thompson
et al., 2010) using digoxigenin-labelled riboprobes against chick
CART1, SOX9 (Healy et al., 1999), AGGRECAN (gift from Prof. Hurle,
Chimal-Monroy et al., 2003), AXIN2 (a gift from Prof Francis West) or
CRABP1 (Maden et al., 1992) or mouse Cart1 (a gift from Prof. P.ression of CART1 (A, A′), SOX9 (B, B′) and AGGRECAN (C, C′) genes in chick embryos, in
(C′) region of eye. CART1 is expressed as a thick band around the optic cup (A) in the
e at HH stage 23 (E4). Expression of SOX9 is seen as a narrow band surrounding the optic
nd the chick optic cup (C), at a slight distance from the RPE (C′) seen here at HH stages
tion (D′), showing a thin band of cartilage surrounding the optic cup at a short distance
s 28 and 29 (E6; F) and HH stage 34 (E8; G). The loose mesenchyme at E4 is starting to
drocytes can be seen (F). At E8 (G), a choroid layer (ch) is seen adjacent to the RPE and
ons at HH stages 30 and 31 (E7) showing the differing stages of cartilage development
gions (J). (K) Diagram illustrating when cartilage markers are expressed in relation to
HH stages 18–29 (E3bE6) and AGGRECAN is seen from HH stage 26 (E5) onwards. Mes,
43H. Thompson et al. / Developmental Biology 347 (2010) 40–52Sharpe), Sox9 (a gift from Prof. P. Sharpe) or Aggrecan (gift from Dr. A
Grigoriadis, Glumoff et al., 1994). Embryos were viewed as whole
mounts or sectioned. For sectioning, heads were placed in 20%
gelatine/PBS for 1 h at 55 °C, embedded, ﬁxed overnight in ice-cold 4%
PFA/PBS and sectioned transversely at 50 μm on a vibratome or cryo-
embedded and sectioned at 25 μm on a cryostat and mounted using90% glycerol PBS or stained with nuclear fast red (Vector Labs) for 1
minute before mounting in 90% glycerol PBS.
In situ hybridisation on 8–12 μm parafﬁn sections was performed
in the same way as whole mount in situ but with the following
alterations. Prior to hybridisation, an acetylation step was performed
(0.25% acetic anhydride (Fluka)/0.1 M TEA-HCl) for 10 minutes. The
44 H. Thompson et al. / Developmental Biology 347 (2010) 40–52hybridisation buffer consisted of 50% formamide, 1% Dextran
sulphate, 10% Denhardt's, 250 μg/ml yeast RNA, 0.3 M NaCl, 20 mM
Tris–HCl, 5 mM EDTA, 10 mM Na3PO4, 1% N-lauroylsarcosine sodium
salt and slides were washed in 50% formamide, 2× SSC. Following in
situ hybridisation the sections were counterstained with nuclear fast
red for 1 minute and mounted in 90% glycerol/PBS.
Mouse section in situ hybridisation (Thompson et al., 2006) was
performed on cryosections. Embryonic heads were sectioned hori-
zontally at 30 μm. Digoxigenin-labelled riboprobes against mouse
Cart1, Sox9 or Aggrecan were used and sections were mounted in 90%
glycerol/PBS.
Immunohistochemistry and cell counts
Monoenucleated embryonic heads were cryo-embedded and
sectioned transversely at a thickness of 14 μm. The section containing
the optic disk was used as a marker and was taken along with 7
consecutive sections. These were incubated with rabbit IgG anti-
phospho-histone H3 (Ser 10) (Upstate Biotechnology, Lake Placid, NY;
1:100) followed by goat anti-rabbit HRP secondary antibody (Invitro-
gen; 1:200). The number of mitotic cells was counted in a 150-μm2
box from each section in a total of 5 animals. On the non-enucleated
control side of the embryo, the box was positioned temporal to the
eye abutting the RPE and ectoderm so as to contain only mesenchyme
cells. A box was positioned on the enucleated side of the section in an
equivalent position. Statistical analysis was performed using the
paired t-test.
Immunostaining
Embryonic heads were ﬁxed in 4% PFA, embedded in parafﬁn wax
before sectioning transversely at 8–16 μm. Slides were dewaxed,
rehydrated and treated with 0.03% hydrogen peroxide for 10 minutes.
Antigen retrievalwasperformed in boiling0.04% citric acid solution pH6
(Sigma) for 10 minutes. Sectionswere then digestedwith 0.25 units/ml
chondroitinase ABC (Sigma) and 1.45 units/ml hyaluronidase (Sigma-
Aldrich) at 37 °C for 30 minutes before overnight incubation in mouse
anti-QCPN (1:1; DSHB, Iowa City, USA), rabbit polyclonal anti-collagen
type II (1:15; Novocastra/Leica, Newcastle, UK), rabbit polyclonal anti-
Phospho-Smad1/5/8 (1:250; without enzyme treatment; Cell Signal-
ling/New England Biolabs, Hitchin, UK) or rabbit polyclonal anti-Sox9
(1:100;Millipore, UK). The sectionswerewashed and incubated in goat
anti-rabbit-488 (Molecular probes/Invitrogen, Paisley, UK), goat anti-
mouse-546 (Molecular probes) or goat anti-mouse-HRP. The sections
were washed and either developed with DAB or mounted in
VectorMount with DAPI (VectorLabs) and imaged under a Leica
DM4000B ﬂuorescent microscope.
Results
Identiﬁcation of scleral cartilage in ocular mesenchyme
Alcian blue (cartilage) and alizarin red (bone) staining of whole
embryonic chick headswas performed to visualise the scleral cartilage
cup surrounding the eyes at HH stage 36 (E10) (Figs. 1C, D). At this
stage the eyes are relatively large and protrude out of the skull. The
scleral cartilage can clearly be seen, covering the majority of the eye.
Alcian blue staining is not present in the anterior most part of the eye,
namely the cornea over the lens and iris. A number of other cranial
cartilage elements are beginning to form and ossiﬁcation of bone has
begun with those most developed found in the beak. At this stage,
bone is not seen within the chick sclera.
To determine the exact location of the scleral cartilage in relation
to the other components of the eye, HH stage 36 chick heads were
sectioned and the cartilage stained with Alcian blue and counter-
stained with nuclear fast red. At this stage, cartilage encircles the eyesurrounding the central and peripheral regions of the retina (Fig. 1E)
at a slight distance from the RPE, with the blood vessels and cells of
the choroid between those two layers (Fig. 1F). This cartilage struc-
ture forms a cuplike shape with a hole centrally, through which the
optic nerve passes and is separated from the RPE by a thin layer of
choroid tissue.
Phases of scleral cartilage development
To characterise the development of the scleral cartilage we
analysed a panel of genes that mark different stages of cartilage
differentiation. The earliest marker present in the ocular mesenchyme
is CART1, which is a very early marker of pre-committed cartilage. It is
expressed from HH stage 16 (E2.5) and by HH stage 23 (E4) is seen in
a broad band around the optic cup with stronger expression nasally
(Fig. 2A). Sections indicate expression is in the mesenchyme adjacent
to the RPE (Fig. 2A′). This expression persists up to HH stage 29 (E6)
(Fig. 2K). SOX9, also a marker of pre-committed cartilage, is clearly
detected completely surrounding the optic cup. Expression is seen in a
narrow band in the ocularmesenchyme at HH stage 23 (E4; Figs. 2B, B′)
following initiation atHHstage 18and continues until approximately E6
(Fig. 2K). AGGRECAN is a matrix protein that is ﬁrst expressed as
chondrocytes differentiate; it is expressed in the ocular mesenchyme
and is initially seen in patches fromHH stage 25 (E5) andmore robustly
from HH stage 28 (E6) (Figs. 2C, K). In contrast to the early cartilage
markers, its expression is restricted to a tight band at a slight distance
from the RPE (Fig. 2C′). The tissue between the RPE and the AGGRECAN
expressing cartilage is the developing choroid. The AGGRECAN expres-
sionpattern is similar to theAlcianblue staining seen atHHstage34 (E8,
Figs. 2D, D′), which shows a thin band of staining at a slight distance
from the RPE. AGGRECAN expression and Alcian blue staining differ-
entiates the developing scleral cartilage from the non-cartilage sclera
(ﬁbrous sclera) and choroid. From the earliest gene expression up to
deﬁnitive cartilage formation and matrix production, this process
comprises of around 5.5 days.
To correlate these expression patterns with cellular events, we
examined H&E stained sections of the ocular territory. Early cartilage
marker expression patterns (CART1, SOX9) coincide with condensa-
tion of mesenchyme adjacent to the RPE, which can be seen robustly
at HH stages 23-24 (E4) (Fig. 2E). By HH stage 29 (E6), mesenchyme
at a distance from the RPE has also condensed and even though
AGGRECAN is marking future scleral cartilage clearly, these cells
cannot be distinguished from choroid or ﬁbrous sclera with H&E
(Fig. 2F). By HH stage 34 (E8) a deﬁnitive cartilage is present with
chondrocytes surrounded by matrix (Fig. 2G). At this stage there is an
obvious choroid that is highly vascularised but not yet pigmented.
Interestingly, the scleral cartilage in the posterior (central) eye region
(Figs. 2H, I) is less differentiated compared to that found more
peripherally in the eye (anterior regions; Figs. 2H, J).
CNS-derived tissues are necessary for the development of scleral cartilage
To investigate the role of the CNS-derived ocular tissue in scleral
cartilage development in vivo, the right optic cup was removed from
HH stage 12–14 (E2) embryos. Embryos were re-incubated for 12 h to
4 days before analysing cartilage gene expression or staining with
Alcian blue to visualise the cartilage matrix. The early cartilage
markers CART1 and SOX9 are expressed in the mesenchyme
surrounding the optic cup (Figs. 3A, C) as described above. Following
enucleation, this expression is lost in the peri-ocular mesenchyme
(HH stage 19 (E3) Figs. 3B, D). Analysis at HH stages 15-16 indicated
that expression of CART1was not initiated following enucleation (data
not shown). However, expression of both genes is still seen adjacent
to the nasal placode (Figs. 3A′ and B′), which is known to be required
for nasal/upper jaw skeletal development (Szabo-Rogers et al., 2009).
To conﬁrm that deﬁnitive cartilage does not form, AGGRECAN
Fig. 3. Enucleation leads to loss of cartilage markers in adjacent mesenchyme. Sectioned (A′, B′) and whole-mount embryos (A, B, C, D, E, F, G, H) of the control (left) side of the
embryo (A, A′, C, E, G) compared to theenucleated (right) sideof theembryo (B, B′, D, F,H) showingexpressionofCART1 (A,A′, B, B′), and SOX9 (C,D), bothatHHstage18/9(E3)AGGRECAN at
HH stage29 (E6; E, F) and stainingwithAlcian blue atHH stage39 (E13; G, H). Enucleationswere performed atHH stage 13/4 (E2).CART1, SOX9 andAGGRECAN are expressed around the eye
on the control side of the embryos (arrow heads in A, A′, C, E). Expressions of CART1, SOX9 and AGGRECAN are lost from the peri-ocular region following enucleation (B, D, F). CART1 and SOX9
areexpressed (arrows)around thenasalplacodebothon thecontrol andenucleated sides (dottedgrey line;A,A′, B, B′C,D). Scleral cartilagecanbe seenencircling theeyeon thecontrol sideof
the embryo when stained with Alcian blue (G); however, no staining is seen in the place where the eye would be on the enucleated side. Cartilage can be clearly seen surrounding the
contralateral control eye (arrow) (H). Circles in B, D and H indicate the position where the eye would have been. E; eye.
45H. Thompson et al. / Developmental Biology 347 (2010) 40–52expression and Alcian blue staining were assessed. AGGRECAN
expression is absent from the enucleated side of the embryo,
compared to the control (compare Fig. 3E with Fig. 3F). AGGRECAN
expression is present within the otic capsule on both control and
enucleated sides. Alcian blue staining was also absent in the region
where the eye would have developed (compare Figs. 3G and H). This
demonstrates the presence of the CNS-derived epithelia is required
for scleral cartilage to form in vivo.
Loss of scleral cartilage within orbital mesenchyme could be due to
removal or damage of neural crest cells during enucleation or inabilityof these cells to migrate into the correct region. To determine if this
was the case, in situ hybridisation was performed using the neural
crest marker CRABP1, which labels a large number of neural crest cells
within the head of the HH stage 19 (E3) embryo (Figs. 4A, C). CRABP1
expression was not changed in the peri-ocular mesenchyme after
enucleation, conﬁrming that neural crest cells were present in the
head in the regionwhere the optic cupwas removed (Figs. 4B, C). H&E
staining shows mesenchymal cells have ﬁlled the region where the
optic cup was removed and appear to be developing in the same way
as the surrounding mesenchyme (Fig. 4D). TUNEL analysis was
Fig. 4.Neural crest cells are still present following enucleation. In situ hybridisation of CRABP1 in whole mount (A, B) or in cryosection (C) showing neural crest cells surrounding the
control (left) optic cup (A, C), and in the area where the optic cup would have been (circle) in the enucleated (right) side of the embryo (B, C), at HH stage 19 (E3). Arrows in C
indicate neural crest cells. This shows neural crest cells were not removed during the enucleation and can be found surrounding the eye at E3. (D) H+E staining of an HH stage 19
(E3) embryo enucleated at HH stage 13 (E2) showing cells ﬁlling the region of the headwhere the eye had been removed. (E) A graph showing the number of TUNEL-positive cells in
a 150-μm2 area temporal and adjacent to the optic cup and in the corresponding region on the enucleated side of the embryo. The embryo was enucleated at HH stage 13 (E2) and
counts were performed at HH stage 19 (E3). There is no signiﬁcant difference in the number of TUNEL-positive cells (pb0.05).
46 H. Thompson et al. / Developmental Biology 347 (2010) 40–52performed comparing the number of peri-ocular mesenchymal cells
dying in the enucleated side of the embryo with the equivalent region
in the contralateral control. An average of 1.6 TUNEL-positive cells
was found in the mesenchyme on the control side of the embryos
compared to 2.2 TUNEL-positive cells in the mesenchyme on the
enucleated side (Fig. 4E). Even though there is a slight increase
following enucleation, this was not signiﬁcantly different (paired t-
test; pb0.05). Therefore, it is loss of the CNS-derived layers of the eye
not loss of the ocular mesenchyme that results in lack of scleral
cartilage development.
The RPE induces cartilage development
Previous in vitro studies suggested that RPE might induce the
formation of cartilage from cranial neural crest (Newsome, 1972;
Stewart and McCallion, 1975; Smith and Thorogood, 1983). To
demonstrate that this occurs in vivo, RPE from HH stages 18-19 (E3)embryos was dissected away from neural retina and grafted into
equivalent stage cranial mesenchyme temporal to the eye, in a region
where cartilage does not normally form (Fig. 5A). To determine if the
RPE graft has the ability to induce the earliest cartilage markers,
embryos were collected at HH stages 22–24. Of the 22 chicks grafted,
10 survived of which 8 retained the graft (36% success rate). In 6 of
these, SOX9 expression was analysed using in situ hybridisation. At
this stage the RPE has become pigmented and can be clearly
distinguished (arrow head in Figs. 5B, C) within the mesenchyme
just under the surface of the ectoderm (Fig. 5C). In 3/6 embryos
analysed, the graft was surrounded by SOX9 expressing cells,
indicating that RPE has the ability to initiate the cartilage develop-
ment pathway in this mesenchyme.
To assess whether RPE grafts could induce the formation of mature
cartilage in vivo, embryos were incubated up to HH stage 34 (E8) and
stained with Alcian blue. Of 72 embryos grafted, 14 survived of which
6 retained grafts (8% success rate). A large pigmented graft
Fig. 5. RPE induces cartilage in cranial neural crest and presumptive ﬁbrous sclera. (A) Schematic illustrating how the grafting experiments were performed. First the optic cup of an HH
stage 19 (E3) chick or Q stage 19 (E3) quail embryowas removed, then the RPE or retinawas dissected away from the other ocular tissues and grafted into the head of anHH stage 19 (E3)
chick embryo or into the space left by the removed optic cup in an HH stage 13 (E2) chick embryo. (B–C) In situ hybridisation using a probe against SOX9, seen as whole-mount (B) or
in section (C) on HH stages 22–24 (E4) embryos following grafting at HH stage 19 (E3). Expression of SOX9 (arrow) is seen around the grafted pigmented RPE tissue (arrow head).
(D–E) Alcian blue staining of cartilage seen inwhole-mount HH stage 34 (E8) embryos (D) or in section with nuclear fast red staining at HH stage 36 (E10) (E), following grafting at
HH stage 19 (E3). Alcian blue staining (arrow) is seen around the ectopic RPE graft (arrowhead). There is a gap between the cartilage and the graft (*) equivalent to the choroid layer
in the normal eye. (F) Alcian blue staining in section at HH stage 36 (E10) with an RPE graft positioned close to the eye showing the ectopic induction of cartilage (arrow) within
tissue that would normally form ﬁbrous sclera (bounded by red dashed line) and in mesenchyme further away from the eye. (G) Immunostaining against SOX9 (green) with DAPI
labelling the nuclei (blue) of sectioned HH stage 28 (E6) showing an RPE graft (arrow head) that was placed in the hole left by the removed optic cup at HH stages 12–14 (E2). This
shows a rescue of SOX9 expression. (H) Immunostaining against QCPN labels the quail retina graft (red) and collagen II labels cartilage (green)with DAPI labelling nuclei (blue). The
retina does not induce cartilage. (I) Grafting with Q stage 19 (E3) quail RPE into HH stage 19 (E3) chick and immunostainingwith QCPN shows only a small number of mesenchyme
cells are transferred along with the RPE graft. These are found very close to the graft. Scale: 250 μm (E), 500 μm (H) and 200 μm (I).
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embryos this was surrounded by strong Alcian blue staining (n=6/
6). In order to see deﬁnitive cartilage cells, grafted embryos were also
left until HH stage 36 (E10) and sectioned (12 grafted, 3 survived, 3
with grafts) before staining with Alcian blue or immunostaining
against collagen II (data not shown). In all embryos examined (n=3/
3), the RPE graft was surrounded by a large mass of ectopic cartilage(Fig. 5E). Interestingly, cartilage cells did not abut the graft, but
formed at a slight distance from it, reminiscent of the architecture of
the ocular mesenchyme, where the choroid layer forms between RPE
and cartilage (Fig. 1F). Of those grafted embryos where SOX9 was not
induced (n=3), one had the graft in a position next to the neural tube
where there is little mesenchyme. The remaining 2 embryosmay have
not been in place for sufﬁcient time to induce SOX9 expression, as all
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cartilage (Figs. 5D, E; 6 at HH stage 34 and 3 at HH stage 36). In these
experiments, most of the RPE grafts were found at a slight distance
from the eye. A few of them, however, were found within the
developing ﬁbrous sclera. These grafts were surrounded by ectopic
cartilage (Fig. 5F) showing RPE has the ability to transform ﬁbrous
sclera into mature scleral cartilage.
To determine whether RPE has the ability to rescue the cartilage
development pathway lost followingoptic cup removal,HHstages18-19
(E3) RPE was grafted into the cavity left by optic cup removal in an HH
stages 12–14 (E2). Embryos were collected after 3 days incubation (8
grafted, 8 survived, 5 with grafts) and cartilage development analysed
using the anti-SOX9 antibody, which showed induction in cells
completely surrounding the graft (Fig. 5G).
In contrast to the RPE's ability to induce cartilage, grafts of the
neural retina do not induce cartilage (Fig. 5H; n=3/3). Quail neural
retina was grafted in the same way as the RPE and an anti-QCPN
antibody used to identify transplanted tissue in the headmesenchyme
and a collagen type II antibody used to detect deﬁnitive cartilage.
Alcian blue staining could not be used to detect cartilage on slides
immunostained for QPCN, as the enzymatic treatment required for
this antibody digests the extracellular matrix that binds Alcian blue.
Thus, it is the RPE and not neural retina that has the ability to induce
cartilage in mesenchyme.
To conﬁrm that RPE grafts do not transfer signiﬁcant amounts of
mesenchyme, quail RPE was grafted and anti-QCPN antibody used to
detect any quail-positive mesenchyme (Fig. 5I, n=4/4). Only a small
number of cells were grafted along with the RPE, and these remained
closely associated with it. Hence, these do not explain the large
number of ectopic cartilage cells surrounding the graft. Additionally,
as these quail mesenchyme cells are found so close to the RPE, they
would contribute to, but not totally account for, the non-cartilage
tissue that is found immediately adjacent to and surrounding each
graft (* in Fig. 5E).
Mice do not have scleral cartilage but do express early cartilage markers
Unlike the majority of vertebrates, mammals do not have a
cartilage layer within the sclera (Franz-Odendaal and Vickaryous,
2006). Using Alcian blue as a marker for cartilage we conﬁrmed that
this is the case in themouse embryo (Figs. 6A–C).Whole-mount E15.5
mouse heads were stained with Alcian blue and Alizarin red. Other
cranial cartilages are well differentiated and eye development is
roughly equivalent to the HH stage 36 (E10) chick (Fig. 6A). Sections
of the head at this stage show a faint blue staining adjacent to the
optic cup, but no deﬁnitive cartilage within the sclera (Figs. 6B, C).
This was also examined in E17.5 mouse heads and deﬁnitive scleral
cartilage was also not present at this stage (data not shown).
To investigatewhether the cartilage differentiation pathway is never
initiated in themouse, orwhether it starts to develop and is then halted,
early cartilage markers were analysed using in situ hybridisation.
Surprisingly, the early cartilage marker Cart1 is very strongly expressed
surrounding the optic cup at E10.5 (Figs. 6D, D′, I) and, as seen in chick,
this expression is stronger nasally. Furthermore, Sox9 is also expressed
adjacent to the mouse RPE at E11.5 (Figs. 6E, E′, I); however, this is at a
lower level than seen in chickandcanonlybe identiﬁed clearly in section
(Fig. 6E′). The expression within the sclera of the late cartilage marker
Aggrecan isweak andpatchy at E12.5 however this cannot bedetected at
later stages (Figs. 6F, F′, I). It is important to note that expression seen
around the eye in whole mounts (arrowhead in Figs. 6E, F) is found
within thedeveloping eyelids not the sclera. Thus, themouse sclera does
express early cartilage markers robustly but later markers are weak or
absent.
The ability of mouse peri-ocular mesenchyme to form mature
cartilage in vitrowas established by performing micromass cultures of
this tissue taken from E12.5 embryos (Fig. 6G). When cultured for4 days, all 12 cultures (16 embryos, 2 litters) produced cartilage
nodules with an average of 3 nodules per culture (Fig. 6H), suggesting
this tissue has the ability to form mature cartilage but is unable to do
so in vivo. The fact that the early cartilagemarkers are expressed in the
mouse sclera suggests that the cartilage pathway is activated as in
other vertebrates. However, it only progresses in a few cells that never
fully mature and produce matrix, highlighting a key difference
between bird and mammalian scleral development.
The difference between scleral development in chick and mouse
could be due to differences in the RPE, with mouse RPE having the
inability to induce cartilage en mass. To test whether mouse RPE can
induce cartilage in competent mesenchyme, mouse RPE (E10.5–11.5)
was grafted into HH stages 18–19 (E3) chick cranial mesenchyme as
above. Unfortunately, only 4/65 embryos grafted with E10.5 RPE and
20/75 grafted with E11.5 RPE survived. Of these no grafts were seen,
and we were therefore unable to test this theory. It could be that
mouse RPE is dispersed, extruded or unable to grow large enough to
be detected.
Investigating signalling pathways involved in scleral cartilage development
There are a number of signalling molecules known to regulate
cartilage development, many of which are known to also play a role in
development of the RPE. Retinoic acid (RA) is one such molecule. To
investigate the effect of retinoic acid on scleral cartilage development,
the optic cup was removed at HH stages 12–14 (E2) and an RA-soaked
bead inserted into the cavity (Fig. 7A). After 2 days, the embryos were
collected and anti-SOX9 antibody used to detect activation of the
cartilage pathway (Fig. 7B). With 0.1 mg/ml RA, a small number of
mesenchymal cells immediately adjacent to the bead were positive
for SOX9. However, 1 mg/ml RA did not induce this expression. This
suggests that low concentrations of RA may have a role in scleral
cartilage induction, but it is unlikely to be the main factor involved.
AXIN2 is transcriptionally regulated by theWnt pathway (Jho et al.,
2002). Thus, it can act as a read-out of Wnt signalling. A number of
Wnts are expressed by the RPE (Jin et al., 2002) and could be
signalling to induce scleral cartilage. Using whole-mount in situ
hybridisation, AXIN2 expression was seen around the temporal
regions of the eye at HH stages 20–25 (Fig. 7D, HH stage 20), but
not corresponding to the developing scleral cartilage (dashed ring in
Fig. 7D). This suggests that Wnts do not have a role in early scleral
cartilage development. Furthermore, a HH stages 18-19 (E3) RPE graft
inserted into the cavity of a HH stages 12–14 (E2) enucleated embryo
and incubated for 3 days does not induce ectopic AXIN2 expression in
the mesenchyme surrounding the graft (Fig. 7E).
BMPs are another group of signalling molecules known to play a
role in RPE development (Müller et al., 2007). To test whether BMPs
are signalling from the RPE to induce cartilage in the surrounding
neural crest-derived mesenchyme, an antibody against PHOSPHO-
SMAD1/5/8 was used. At HH stages 20–27 (E4–6) there are few
positive cells found within the presumptive scleral cartilage (Fig. 7G,
HH stage 25). Similarly, grafting of a HH stages 18-19 (E3) RPE into
the cavity of a HH stages 12–14 (E2) enucleated embryo did not result
in an increase in PHOSPHO-SMAD1/5/8-positive cells in the peri-
orbital mesenchyme surrounding the replacement graft (Fig. 7H).
These data suggest that Wnt and Bmp are not the key molecules
involved in scleral cartilage development.
Discussion
This paper is the ﬁrst in depth analysis of scleral cartilage
development in the whole animal. We have found that it occurs in a
series of deﬁned developmental stages with expression of pre-
commitment cartilage markers (SOX9 and CART1) preceding that of
the later cartilage marker AGGRECAN and the deﬁnitive cartilage
Alcian blue stain. CART1 and SOX9 are ﬁrst expressed at HH stage 15
Fig. 6.Mouse peri-ocular mesenchyme expresses early cartilage markers and has the ability to produce cartilage in vitro, but no cartilage forms in vivo. Whole-mount Alcian blue and
alizarin red stain (A) and sectioned Alcian blue and nuclear fast red stain (B–C) of E15.5 mouse embryo showing absence of cartilage surrounding the eye or near the RPE. However,
other cranial cartilages have formed by this stage (c). (D–F) In situ hybridisation showing expression of Cart1 at E10.5 (D, D′), Sox9 at E11.5 (E, E′) and Aggrecan at E12.5 (F, F′) in
mouse in whole-mount (D, E, F) and in section (D′, E′, F′). Cart1 is expressed around the optic cup with stronger expression nasally (D, D′) at E10.5 (I), Sox9 is expressed around the
optic cup adjacent to the RPE (E′) at E11.5 (I) the expression is weak and cannot be seen in whole-mount (E). Aggrecan is not expressed in the mouse adjacent to the RPE at any
signiﬁcant level (F, F′, I). Sox9 and Aggrecan expression can be seen in the eyelids at a slight distance from the eye (arrow heads in E, F). (G) Schematic illustrating the location of the
peri-ocular mesenchyme from which the neural crest cells were taken for micromass culture. (H) An Alcian blue stained micromass culture of mouse peri-ocular mesenchyme,
showing an example of a cartilage nodule. (I) Diagram illustrating when cartilage markers are expressed. C, cartilage; scl, sclera; mes, mesenchyme.
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Fig. 7. Investigation of signalling pathways involvedwith scleral cartilage development (A) Schematic illustrating removal of the optic cup from an HH stages 12–14 (E2) embryo and
its replacement with an RA-soaked bead. (B, C) Pseudo-coloured immunostaining against SOX9 (white) with DAPI labelling of nuclei (purple), showing low expression in cells
(arrows) surrounding the RA bead (*; B). Strong SOX9 expression can be seen in other regions of the head (arrows in C). (D) In situ hybridisation of a whole-mount embryo showing
expression of AXIN2 at HH stage 20 (E4), expression is seen surrounding the temporal region of the eye outside the region of the developing scleral cartilage (dashed ring). (E, F) In
situ hybridisation of a sectioned embryo where the optic cup was removed at HH stages 12–14 (E2), replaced with HH stage 19 (E3) RPE and collected 3 days later. There is no
upregulation of expression of AXIN2 in the region surrounding the RPE graft (*; E), compared to the strong expression seen elsewhere (arrows in F). (G–I) Immunostaining against
PHOSPHO-SMAD 1/5/8 (green) with auto-ﬂuorescing blood cells (yellow). (G) Staining is seen in cells of the neural retina (nr), RPE and sclera surrounding the eye of an HH stages
25–27 (E5). A small number of positive cells are within the sclera (arrow). A few positive cells (arrows) can be seen around the graft (*; H), but this is far less than expression seen in
other regions of the head (arrows in I).
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around HH stage 26 (E5) and Alcian blue staining is not seen until HH
stage 34 (E8). From start to ﬁnish this process comprises of around
5.5 days. Although the order of these stages ﬁts with previous data
examining limb cartilages, the duration is markedly different, being
signiﬁcantly longer in the head (5.5 days vs. 3 days in the limb)
(Melnick et al., 1981; Chimal-Monroy et al., 2003). This may reﬂect
the need to delay overt cartilage formation due to rapid growth of the
CNS during these stages of development.
Previous papers had examined the ability of eye structures to
direct cartilage development in mesenchyme in vitro (CAM grafts)
and suggested that the RPE played a role in this process (Newsome,
1972; Stewart and McCallion, 1975; Smith and Thorogood, 1983).
However, the analysis was limited to non-speciﬁc histological staining
and the presumptive cartilage formed as rods or pellets immediately
adjacent to the RPE, without any evidence of a choroid. This is unlike
normal scleral cartilage in vivo, which is a sheet of cartilage that
surrounds the RPE but is separated from it by a choroid layer. We have
extended these previous analyses to the in vivo system and show that
the absence of the optic cup results in loss of scleral cartilage. Grafting
of RPE into scleral mesenchyme can induce cartilage formation and in
the absence of an eye, an RPE graft alone can induce the expression of
cartilage markers such as SOX9. Also, grafting of RPE but not retinainduces scleral cartilage in neural crest-derived mesenchyme that
normally only forms bone. Importantly, all of these grafts adopted a
similar structure to that in the normal eye, namely an RPE core,
surrounded by a cartilage sheet. Interestingly, we found that these
grafts also possessed a distinct non-cartilage layer, the presumptive
choroid, similar to that found in the normal eye. This supports
previous data that highlight the importance of RPE in choroid
development (Zhao and Overbeek, 2001) and suggests that the
chick RPE not only directs scleral cartilage formation but also
inﬂuences choroid formation. This would imply that a diffusible
factor is involved in scleral cartilage induction, data which is
contradictory to that found by Smith and Thorogood (1983). In our
quail grafting experiments, small numbers of mesenchymal cells were
carried with the RPE graft and contributed to the presumptive choroid
region and it could be suggested that it is these cells and not the RPE
graft that carries the signal for cartilage induction. It has been shown
that culturing early peri-ocular mesenchyme in CAM culture, which
would also contain these presumptive choroid cells, does not result in
the induction of cartilage (Newsome, 1972). However, we do not rule
out later reciprocal signalling between these tissues being required for
normal development.
Our in vivo analysis has also allowed us to ask whether the RPE has
an inductive or merely a maintenance role in cartilage development.
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cartilage are not switched on after removal of the optic cup, indicating
that it induces the expression of these genes and that grafts of the RPE
can ectopically induce them. Similarly we can say that it does not
simply play a maintenance role in cell survival, as we did not see
dramatic cell death of the mesenchyme surrounding it. Thus, the RPE
has an inductive role in cartilage development and differentiation in
vivo.
In order to identify the nature of the signal that emanates from the
RPE, we have examined a number of signalling pathways that play a
role in both cartilage and RPE development. Retinoic acid signalling is
known to play a role in eye development (reviewed by Cvekl and
Wang, 2009) and it has been demonstrated that the RPE synthesises
RA throughout development (Mey et al., 2001; Prabhudesai et al.,
2005). RA signalling plays a role in skeletal patterning and it has been
shown that application of RA to the limb or upper beak (the latter in
conjunction with Noggin) causes duplication of skeletal elements
(Tickle et al., 1982; Lee et al., 2001). However, analysis of the effect of
RA signalling on limb mesenchymal cultures shows that RA inhibits
SOX9 expression and prevents cartilage differentiation (Weston et al.,
2002). In contrast, we saw some induction of SOX9 expression in
mesenchyme immediately adjacent to the bead using low concentra-
tions of RA, indicating that it may indeed play a role in the induction
of cartilage by the RPE. However, the low level of this induction
indicates that RA signalling is unlikely to be the primarymechanism of
induction.
The canonical Wnt signalling pathway has recently been identiﬁed
as a key player in RPE development (Westenskow et al., 2009;
Fujimura et al., 2009). Similarly the role of Wnt signalling in cartilage
development has been well studied and indicates that Wnt signalling
can both inhibit and promote cartilage development (Yano et al.,
2005; Rudnicki and Brown, 1997; Church et al., 2002, reviewed in
Chun et al., 2008). Analysis of the expression of Axin2, which is
transcriptionally induced by Wnt signalling, indicates while there is
active signalling in the peri-ocular mesenchyme, it is not in the
cartilage anlagen. This is consistent with the ﬁndings of many studies
indicating that Wnt signalling inhibits early cartilage development. In
keepingwith this, RPE grafts were unable to induce Axin2 signalling in
adjacent mesenchyme.
BMP signalling is known to be critical for RPE development and is
found expressed in the RPE at many stages of development (Müller
et al., 2007). BMP signalling also regulates every phase of cartilage
development from condensation to hypertrophy (reviewed by Wu
et al., 2007). Analysis of pSMAD 1/5/8 expression demonstrated that
it was not present at high levels in the sclera mesenchyme during
early development. RPE grafts did not induce high levels of pSMAD1/
5/8 in adjacent mesenchyme, indicating that, similar to Wnt, BMP
signalling through the SMAD pathway is unlikely to be playing a
major role in induction of sclera cartilage by the RPE.
Itmust be noted that these experiments have not addressed the role
of RPE in the development of the ﬁbrous sclera. It has been shown that
proliferation of chick ﬁbrous scleral cells in culture requires co-culture
with RPE (Seko et al., 1994), implying a diffusible RPE signal inﬂuences
scleral development. The transcription factor Pitx2 is required for
adoption of the sclera fate (Evans and Gage, 2005) and it has recently
been shown that RA from the optic cup induces Pitx2 expression in the
anterior chamber of the eye (Gage and Zacharias, 2009; Kumar and
Duester, 2010). Thus, it is possible that RA signalling from the RPE
weakly induces sclera cartilage markers (SOX9) but strongly induces
sclera markers (PITX2) along a gradient, thus directing fate choices
within the neural crest population that forms both of these cell types.
While, scleral cartilage can be seen surrounding, and at a short
distance, from the RPE, it is not continuous around the whole eye, as
there is a gap for the optic nerve to exit the eye and there is no cartilage
covering the iris or cornea. This suggests inhibitory molecules may play
a role in the formation of correct cartilage shape, and it would beinteresting to look at expressionof knowncartilage inhibitorymolecules
in these regions. Interestingly, in someﬁsh, the shape of scleral cartilage
is different (Franz-Odendaal and Hall, 2006; Franz-Odendaal and
Vickaryous, 2006), it forms a ring around the eye rather than a cup,
this couldbedue todifferingexpressionpatternsof inhibitorymolecules
or to differences in the inductive potential of the RPE.
Our analysis shows that scleral cartilage differentiation does not
occur concurrently around the eye but is initiated anteriorly, adjacent to
the peripheral retina and then progresses posteriorly. In contrast, the
retina and RPE mature in the opposite direction with terminal
differentiation of retinal and RPE cells occurring ﬁrst in central regions
(McCabe et al., 1999). However, the pigmentation of the RPE is in
an identical pattern to the cartilage differentiation, suggesting an
intriguing link between the development of pigmentation and cartilage.
Mammals are a vertebrate group that does not possess a scleral
cartilage. However, we have shown in mice that this structure does
start to form but that this developmental process is arrested. In
addition we have shown that mouse scleral mesenchyme is able to
make cartilage in vitro, albeit at relatively low levels. This might
suggest that there are small populations of cells within the mouse
sclera that retain their cartilage potential and act as a stem cell
population. Intriguingly, there are pathological instances where
scleral cartilage and bone have been reported in human sclera
(Traboulsi et al., 1999; Pecorella et al., 2006) and there is also a link
between diseases of cartilage and the sclera. Both the sclera and joint
cartilage are common targets in rheumatoid arthritis (Seko et al.,
2008), an autoimmune disease that predominantly attacks the joints
causing inﬂammation and progressive tissue destruction, but which
also causes chronic scleral inﬂammation known as refractory scleritis.
Microarray data on cultured human infant scleral cells showed similar
proﬁle to cartilage derived cells, and culture studies of this tissue lead
to the expression of cartilage-associated genes (Seko et al., 2008).
These data suggest that human sclera may retain the ability to form
cartilage as in other vertebrates, and be affected by cartilage diseases.
Our data suggest that during mouse development scleral mesen-
chyme does undergo at least the earliest phases of cartilage
development and that stem cells with the ability to form cartilage
may remain in this tissue. In certain pathological conditions this may
be further elaborated in the adult. In light of this it is also interesting
to note that a high proportion of aging rats have cartilage formation in
the sclera (O'Steen and Brodish, 1990). Thus, this may not only be a
mechanism in pathological disease but may also occur due to aging.
In conclusion, we have shown the stages of scleral cartilage
development in the chick and found that this cartilage develops over
an extended period of time compared to limb cartilage. We highlight
the importance the optic cup in initiation of scleral cartilage
development and prove in vivo that the RPE is the tissue that induces
this cartilage. Furthermore, we found that even though mammals do
not have scleral cartilage, cartilage development is initiated in mouse.Acknowledgments
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